2022
DOI: 10.1016/j.xpro.2022.101697
|View full text |Cite
|
Sign up to set email alerts
|

Protocol for large scale whole blood immune monitoring by mass cytometry and Cyto Quality Pipeline

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
2
1

Relationship

2
5

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 26 publications
0
8
0
Order By: Relevance
“…Cells were acquired on a mass cytometer (HELIOS, Standard BioTools) at an event rate of 400 cells/s together with EQ Four Element Calibration Beads (Standard BioTools). Raw data were normalized using CytoQP function bead_normalize ( 26 ). FlowJo software v10.0 was used to analyse normalized data by manual gating.…”
Section: Methodsmentioning
confidence: 99%
“…Cells were acquired on a mass cytometer (HELIOS, Standard BioTools) at an event rate of 400 cells/s together with EQ Four Element Calibration Beads (Standard BioTools). Raw data were normalized using CytoQP function bead_normalize ( 26 ). FlowJo software v10.0 was used to analyse normalized data by manual gating.…”
Section: Methodsmentioning
confidence: 99%
“…Blood samples were thawed, lysed and stained for surface markers as described 21 . Briefly, 1.5*10 6 cells/sample were used for the barcoding with Cell-ID 20-Plex Pd Barcoding Kit (Standard BioTools).…”
Section: Sample Staining and Acquisition On Cytof/heliosmentioning
confidence: 99%
“…Epigenetic modification by environmental signals is implicated in the pathogenesis of SSc in genetically susceptible individuals [ 144 ]. Advances in technologies, such as cytometry by time of flight (CyTOF), are promising with the possibility to now look at cellular markers in whole blood, including platelet and red blood cells [ 145 , 146 , 147 ]. Furthermore, the Extended Polydimensional Immunome Characterization (EPIC), a web-based tool, could be used for the analysis of high-dimensional biomarkers in SSc patients compared with datasets of healthy controls [ 148 ].…”
Section: Unmet Needs and Future Studiesmentioning
confidence: 99%